Related Experiment Video
Updated: Aug 7, 2026
04:25
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisons
Jonathan B McHugh1, Dafydd G Thomas, Joseph M Herman
1Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109-0054, USA.
Cancer
|June 24, 2006
Summary
Radiation-associated craniofacial osteosarcomas are aggressive, high-grade tumors. These tumors show higher rates of adverse prognostic indicators compared to primary craniofacial osteosarcomas, indicating a distinct biological behavior.
Area of Science:
- Oncology
- Skeletal Biology
- Cancer Research
Background:
- Craniofacial osteosarcomas typically present in older patients with a more favorable prognosis compared to long bone osteosarcomas.
- While most cases are sporadic, some craniofacial osteosarcomas arise secondary to prior radiation therapy.
Purpose of the Study:
- To compare the clinicopathologic and prognostic features of primary versus radiation-associated craniofacial osteosarcomas.
Main Methods:
- Analysis of 15 primary and 6 radiation-associated craniofacial osteosarcomas.
- Immunohistochemical staining for p53, pRB, Ki-67 (MIB-1), and ezrin.
- TP53 mutation analysis via DNA sequencing.
Main Results:
- Radiation-associated osteosarcomas were exclusively high-grade, with 50% being fibroblastic, unlike primary tumors (47% high-grade, 1 fibroblastic).
- All radiation-associated tumors recurred, with a higher mortality rate (50%) and less favorable outcomes (2 alive with unresectable disease) compared to primary tumors (80% alive without disease).
- Radiation-associated tumors exhibited increased p53 overexpression (33% vs. 13%), TP53 mutations (33% vs. 8%), higher proliferation (67% vs. 0% MIB-1 >50%), and more frequent ezrin expression (83% vs. 40%).
Conclusions:
- Craniofacial osteosarcomas linked to radiation therapy are high-grade and exhibit more aggressive behavior than typical primary craniofacial osteosarcomas.
- Elevated expression of adverse prognostic markers in radiation-associated tumors underscores their distinct clinicopathologic profile.
